Other
Drug Facts
Dist. by: RB Health (US)
Parsippany, NJ 07054-0224
Made in England
The following Structured Product Label (SPL) was submitted to the FDA by Select Consumer Group for the product Mucinex Dm (NDC 85237-1650). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, otc - active ingredient, otc - purpose, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Dist. by: RB Health (US)
Parsippany, NJ 07054-0224
Made in England
Active ingredients (in each extended-release tablet)
Dextromethorphan HBr 30 mg
Guaifenesin 600 mg
| Active ingredients (in each extended-release tablet) | Purposes |
|---|---|
| Dextromethorphan HBr 30 mg | Cough suppressant |
| Guaifenesin 600 mg | Expectorant |
If pregnant or breast-feeding,ask a health professional before use.
Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.
carbomer homopolymer type B; D&C yellow no. 10 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF
1-866-MUCINEX (1-866-682-4639)
NDC 63824-056-32
Mucinex®DM
600 mg guaifenesin & 30 mg dextromethorphan HBr
extended-release tablets
EXPECTORANT & COUGH SUPPRESSANT
12
HOUR
®
20
EXTENDED-RELEASE TABLETS
* Please review the disclaimer below.